Results 231 to 240 of about 380,997 (339)

Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years [PDF]

, 2017
Dehner, Louis P, et al,
core   +1 more source

Prognostic Factors of Castration‐Resistant Prostate Cancer Among Patients With Localized Prostate Cancer Who Underwent Robot‐Assisted Radical Prostatectomy in a Retrospective Multicenter Japanese Cohort (MSUG94)

International Journal of Urology, Volume 33, Issue 2, February 2026.
ABSTRACT Objectives To explore clinicopathological risk factors associated with the development of castration‐resistant prostate cancer (CRPC) in patients who underwent robot‐assisted radical prostatectomy (RARP). Methods This study was conducted in nine Japanese institutions between 2012 and 2021.
Takeshi Sasaki, Atsushi Igarashi, Shin Ebara, Tomoyuki Tatenuma, Yoshinori Ikehata, Akinori Nakayama, Makoto Kawase, Masahiro Toide, Tatsuaki Yoneda, Kazushige Sakaguchi, Jun Teishima, Kazuhide Makiyama, Hiroshi Kitamura, Kazutaka Saito, Takuya Koie, Fumitaka Koga, Shinji Urakami, Toshinari Yamasaki, Takahiro Inoue   +18 more
wiley   +1 more source

Active Propelled Micro Robots in Drug Delivery for Urologic Diseases. [PDF]

Micromachines (Basel)
Zhong C, Tang M, Cong Z.
europepmc   +1 more source

[Brazilian Society of Urology. Guidelines on penile neoplasm].

International braz j urol : official journal of the Brazilian Society of Urology, 2014
Lucio Flávio, Gonzaga-Silva, Stênio de Cássio, Zequi, Agnaldo César, Nardi, Gustavo Franco, Carvalhal, José Carlos, de Almeida, Antonio Carlos Lima, Pompeo, Renato, Scaletscky, André G, Cavalcanti, Antonio Augusto, Ornellas, Carlos Eduardo Corradi, Fonseca, Ubirajara, Ferreira, Marcos Tobias, Machado, Eloísio Alexandro, da Silva, Misael Wanderley, dos Santos Júnior, Alvaro Sadek, Sarkis, Francisco Flávio Horta, Bretas, Rogério Matos, Araújo, Mário Ronalsa, Brandão Filho, Felipe, Dubourq   +18 more
openaire   +1 more source

Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution

International Journal of Cancer, Volume 158, Issue 2, Page 314-332, 15 January 2026.
Abstract Prostate cancer is a common malignancy that in 5%–30% leads to treatment‐resistant and highly aggressive disease. Metastasis‐potential and treatment‐resistance is thought to rely on increased plasticity of the cancer cells—a mechanism whereby cancer cells alter their identity to adapt to changing environments or therapeutic pressures to create
Kira Furlano, Tina Keshavarzian, Nadine Biernath, Annika Fendler, Maria de Santis, Joachim Weischenfeldt, Mathieu Lupien   +6 more
wiley   +1 more source

Urologic Fistulas in Czech Women With Gynaecologic Malignancies. [PDF]

Cancer Rep (Hoboken)
Spacek J, Ndukwe MO, Ubom AEB, Sirak I, Hoffman P, Karasek D, Petera J, Brodak M, Balik M, Habes D, Pacovsky J.   +10 more
europepmc   +1 more source

Publications by Members of the Faculty of The University of Texas [PDF]

, 1939
Brogan, A.P.
core  

Beyond tumour suppression: cGAS-STING pathway in urologic malignancies: Context-dependent duality and therapeutic implications. [PDF]

Clin Transl Med
Wei Q, Zhao K, Wu Y, Wu W, Hao N.
europepmc   +1 more source

[Therapy of urologic neoplasms by interferons].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1986
openaire   +1 more source